InflaRx (IFRX) Revenue (2023 - 2025)
InflaRx's Revenue history spans 3 years, with the latest figure at -$85695.7 for Q4 2025.
- On a quarterly basis, Revenue fell 18858.56% to -$85695.7 in Q4 2025 year-over-year; TTM through Dec 2025 was $113738.0, a 37.34% decrease, with the full-year FY2025 number at $34142.6, down 80.73% from a year prior.
- Revenue hit -$85695.7 in Q4 2025 for InflaRx, down from $116891.5 in the prior quarter.
- Over the last five years, Revenue for IFRX hit a ceiling of $135980.4 in Q3 2024 and a floor of -$85695.7 in Q4 2025.
- Historically, Revenue has averaged $33080.1 across 3 years, with a median of $37906.8 in 2025.
- The widest YoY moves for Revenue: up 552.01% in 2025, down 18858.56% in 2025.
- Tracing IFRX's Revenue over 3 years: stood at $2459.6 in 2023, then tumbled by 118.38% to -$452.02 in 2024, then plummeted by 18858.56% to -$85695.7 in 2025.
- Business Quant data shows Revenue for IFRX at -$85695.7 in Q4 2025, $116891.5 in Q3 2025, and $44635.4 in Q2 2025.